Aller au contenu principal
Accès ouvert déclaré 2025 article

The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members

3Citations signalées, ce qui n’est pas une note de qualité
65Institutions déclarées
29Pays d’affiliation déclarés

Rattachement africain : ie, it, rs, hu, il, tr, gr, pl, bg, fr, be, es, at, us, ru, gb, nl, de, fi, cz, ch, sk, ua, pt, ro, hr, se, dk, by. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Purpose: Treatment-resistant depression (TRD) is most commonly defined as depression that has not responded to two different pharmacological agents used for an adequate period of time. We explored the views of European specialists via survey, regarding the use of thyroid hormone (TH) in euthyroid patients with TRD as part of 'Treatment of Hypothyroidism in Europe by Specialists: An International Survey' (THESIS). Methods: The question "Thyroid hormones may be indicated in biochemically euthyroid patients with treatment resistant depression" was posed to specialists from 28 countries. Results: 5695 valid responses were received following 17,232 invitations (33.0% response rate; 65% female, 90% endocrinologists). 348 (6.1%) stated that TH may be indicated in biochemically euthyroid patients with TRD. This view was more common in males (p<0.01), respondents who saw ≥100 patients with hypothyroidism per year (p<0.01), respondents who worked in private practice (p=0.05) and respondents who were not members of international specialist associations (p=0.05). Geographical variation existed with respondents in Eastern Europe significantly more likely to use TH in TRD (p<0.01). Linear regression showed a statistically significant reduction in the use of TH for TRD with increasing gross national income (F-statistic=7.35, CI -0.15 - -0.02, p=0.01). TH in TRD was recommended in psychiatry guidelines but not endocrinology guidelines. Conclusion: While there is limited evidence for their use, over 6% of respondents stated that TH may be indicated in TRD. Due to the risk of iatrogenic thyrotoxicosis and increased morbidity the use of TH should be addressed in relevant endocrinology guidelines and consensus should be reached between specialties.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The use of thyroid hormones in the treatment of euthyroid patients with treatment-resistant depression. Data from a survey of 5695 European national endocrine professional organization members
Date Crossref
23/09/2025
Éditeur
Frontiers Media SA
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Trinity College DublinTallaght University HospitalUniversity College DublinBeaumont HospitalSt. Vincent's University HospitalAssociazione Medici DiabetologiUniversity of BelgradeUniversity of DebrecenOspedale Vito FazziOspedale Regina ApostolorumTel Aviv UniversityRabin Medical CenterGaziantep UniversityAlexandra HospitalMemorial Ankara HospitalMedical University of WarsawMedical University of SofiaAlexandrovska HospitalSorbonne UniversitéAssistance Publique – Hôpitaux de ParisPitié-Salpêtrière HospitalGroupe de recherche clinique – Tumeurs ThyroïdiennesCliniques Universitaires Saint-LucHospital Universitario Puerta de Hierro MajadahondaInstituto de Investigación Sanitaria de SantiagoUniversidad Autónoma de MadridUniversity of ViennaBone Health and Osteoporosis FoundationSechenov UniversityUniversity of SurreyAmsterdam NeuroscienceUniversity of AmsterdamEssen University HospitalUniversity of Duisburg-EssenNavarre Institute of Health ResearchClinica Universidad de NavarraTampere University HospitalTampere UniversityCharles UniversityGeneral University Hospital in PragueUniversity of LausanneMedical University of ViennaComenius University BratislavaUniversity of Pavol Jozef ŠafárikV.P. Komisarenko Institute of Endocrinology and MetabolismUniversity of CoimbraCarol Davila University of Medicine and PharmacyMercy University HospitalSisters of Charity HospitalSkåne University HospitalHospital de São JoãoUniversity Centre of Legal MedicinePoznan University of Medical SciencesOdense University HospitalBelarusian State Medical UniversityVrije Universiteit BrusselHeidelberg UniversityUniversity Hospital HeidelbergKnappschaftskrankenhaus RecklinghausenUniversity Medical Centre MannheimErasmus University RotterdamHellenic Red CrossEast Surrey HospitalSurrey and Sussex Healthcare NHS TrustNewcastle University

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Thyroid Disorders and TreatmentsThyroid Cancer Diagnosis and TreatmentStress Responses and Cortisol

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.